Home / Resources / Insurance won't cover Ozempic
Coverage problem
Insurance won't cover Ozempic? Here is what to do.
An Ozempic denial usually comes down to one thing: what it was prescribed for. Ozempic is approved for type 2 diabetes, not weight loss, and that distinction drives most denials. Once you know which kind you have, you can appeal it.
We ground every appeal in the FDA label and your plan's own published rules. No invented citations.
What Ozempic is approved for
Type 2 diabetes
Plus cardiovascular risk reduction in certain adults. Not approved for weight loss.
Most common denial driver
Off-label use
When prescribed for weight management, plans often deny Ozempic as not covered for that use.
Your right to appeal
Internal + external
Under the ACA you can ask your plan to reconsider, then get an independent review.
Ozempic (semaglutide) is one of the most requested medications in the country, and one of the most denied. To appeal a denial well, you first have to understand why insurers say no, because the reason determines what your appeal needs to prove.
Start with what Ozempic is approved for
According to its FDA-approved prescribing information, Ozempic is indicated to improve blood sugar control in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and known heart disease. It is not FDA-approved for chronic weight management.
That single fact explains most Ozempic coverage problems. A drug that contains the same active ingredient, semaglutide, is approved for weight management under a different brand. So when Ozempic is prescribed mainly to lose weight, your plan often treats that as an off-label use and denies it on that basis.
The four denials you are most likely to see
Read your denial letter and match it to one of these. The category tells you which path to take.
1. Off-label for weight loss
The plan covers Ozempic for diabetes but not for weight management, and the records suggest it was prescribed for weight. This is the most common Ozempic denial. The appeal here turns on the documented clinical reason for the prescription. If you have type 2 diabetes, that diagnosis and the supporting labs are central. Read the full off-label for weight loss guide.
2. Step therapy, or "try metformin first"
Many plans require a documented trial of a lower-cost diabetes medication, often metformin, before they approve Ozempic. If your records do not show that trial, or show it but it was not submitted, you get denied even when the trial happened. See step therapy.
3. Formulary tier or exclusion
Ozempic may sit on a high formulary tier, or your specific plan may exclude it. Confirm whether the exclusion truly applies to your plan and your diagnosis before assuming it is final. See formulary exclusion.
4. Missing prior authorization or documentation
Sometimes the medicine is covered but a required prior authorization or a key record was not on file. These are often the most fixable denials of all. See missing documentation and our prior authorization for Ozempic guide.
How to appeal an Ozempic denial
The approach is the same one that works across GLP-1 appeals: be specific, be grounded, and be on time.
The move: answer the exact reason on your letter, point to your plan's own published coverage policy for the drug, and ground the medical facts in Ozempic's FDA label. An appeal mapped to the specific rule the reviewer must follow is far stronger than a general request.
- If it is off-label: center the documented clinical indication. If you have type 2 diabetes, lead with that diagnosis and the labs. If the real goal is weight management, understand that the approved weight-management product may be the cleaner path, and your prescriber can advise on that.
- If it is step therapy: attach dated documentation of any prior medications tried, or of a medical reason you could not take them.
- File within the window. Most plans allow 60 to 180 days for an internal appeal; your letter states the exact deadline. If that is denied, you generally have the right to an independent external review.
Sources for an Ozempic appeal include your plan's published coverage policy for GLP-1 drugs and the semaglutide (Ozempic) prescribing information. We cite the specific policy that applies to your plan when we build your appeal.
The magic is visible
Your Ozempic appeal, built from the label and your plan's rules.
We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.
Sample appeal, built from real source types
- Your plan's coverage policyYour insurer's published policy for GLP-1 medications that applies to your planVerified
- FDA labelSemaglutide (Ozempic) prescribing information, type 2 diabetes indicationVerified
- Your recordsYour diagnosis, labs, and prior therapies, cited back accuratelyVerified
Let's check your Ozempic denial, free.
Answer a few questions for an honest read on your options, then a verified draft. No account, no cost.
Check my denial, freeCommon questions
Why won't my insurance cover Ozempic?
Is Ozempic the same as Wegovy?
Can I appeal even if it was prescribed off-label?
Is this really free?
Keep reading: All Ozempic denials · How to appeal a GLP-1 denial · Internal vs external review · All resources